Agonistic CD40 antibody induces immune-mediated liver damage and modulates tumor-induced myeloid suppressive cells

Documenti analoghi

• Systemic agonistic anti-CD40 treatment of tumor bearing mice modulates hepatic myeloid suppressive cells and causes immune-mediated liver damage
  di: Medina-Echeverz, José, et al.
  Pubblicazione: (2015)
• Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage
  di: Eggert, Tobias, et al.
  Pubblicazione: (2014)
• Hepatic myeloid-derived suppressor cells in tumor bearing mice exacerbate hepatitis and transform into pro-inflammatory myeloid cells
  di: Medina-Echeverz, Jose, et al.
  Pubblicazione: (2013)
• ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
  di: Mangsbo, Sara M, et al.
  Pubblicazione: (2013)
• Pre-clinical development of the human CD40 agonistic antibody ADC-1013
  di: Norlén, Per, et al.
  Pubblicazione: (2015)